Borealis Biosciences, a next-generation RNA medicines company, today announced the appointment of Christian Hordo as CEO; a $30 million infusion from an extension of the Series A led by Westlake BioPartners; and the addition of three new board directors, David Allison, Ph.D., Tom Frohlich and Catherine Thut, Ph.D.
There are a lot of American startups funding deals that are creating buzz around the startup ecosystem. These are the growth-stage and early-stage deals of this week. Let’s talk about the Top 10 Funding deals.
Nuvig Therapeutics, Inc., a privately held biotechnology company developing novel immunomodulatory therapeutics for patients with inflammatory autoimmune diseases, announced today the closing of a $161 million Series B financing.
NC-based clinical-stage biotech company, Doron Therapeutics has secured $11M in Series A Funding led by SPRIM Global Investments (SGI) to take MOTYS™ into Phase 3 clinical studies.
There are a lot of American startups funding deals that are creating buzz around the startup ecosystem. These are the growth-stage and early-stage deals...
CrossBridge Bio, a biotechnology company focused on developing advanced cancer treatments using dual-payload antibody-drug conjugates (ADCs), has secured $10 million in funding.
The funding round...
There are a lot of American startups funding deals that are creating buzz around the startup ecosystem. These are the growth-stage and early-stage deals...
Judo Bio, a biotechnology company pioneering oligonucleotide medicines delivered to the kidney, today announced the company’s launch and $100 million in initial financing, including...
There are a lot of American startups funding deals that are creating buzz around the startup ecosystem. These are the growth-stage and early-stage deals...
Integrated Biosciences, a biotechnology company pioneering the use of synthetic biology and machine learning to develop next-generation therapeutics for age-related diseases, today announced that...
